Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.38 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nonylacetate SCHEMBL1870605 | 0.87 | ALDH1A1 (0.50) | ALOX15ALDH1A1TSHRLMNA | |
| SCHEMBL10941091 | 0.87 | ALDH1A1 (0.44) | ALOX15EGFRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL9087682 | 0.86 | EGFR (0.40) | ALOX15EGFRALDH1A1CHRNB2CHRNA4 | |
| SCHEMBL5932536 | 0.84 | EGFR (0.39) | ALOX15EGFRCHRNB2CHRNA4CHRNB4 | |
| SCHEMBL3289278 | 0.84 | EGFR (0.41) | ALOX15EGFRCHRNB2CHRNA4CHRNB4 | |
| SCHEMBL5933627 | 0.84 | EGFR (0.39) | ALOX15EGFRCHRNB2CHRNA4CHRNB4 | |
| SCHEMBL5932523 | 0.84 | EGFR (0.39) | ALOX15EGFRCHRNB2CHRNA4CHRNB4 | |
| SCHEMBL7552905 | 0.83 | ALOX15 (0.70) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL9808875 | 0.82 | TDP1 (0.36) | ALOX15EGFRALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL5933631 | 0.82 | EGFR (0.38) | ALOX15EGFRCHRNB2CHRNA4CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4302747-B1 | SYSTEM FOR DISPENSING A COSMETIC PRODUCT | OREAL (FR) | 2026-01-14 | — | — | EP | claimed |
| US-20250110112-A1 | METHODS AND SYSTEMS FOR RAPID DETECTION OF COVID-19 | THE TRUSTEES OF INDIANA UNIVERSITY | 2025-04-03 | — | — | US | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| US-12239209-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2025-03-04 | — | — | US | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| US-20240399015-A1 | FRAGRANCE AND DISPENSER | RECKITT & COLMAN OVERSEAS HYGIENE HOME LTD (GB) | 2024-12-05 | — | — | US | claimed |
| EP-4415679-A1 | FRAGRANCE AND DISPENSER | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2024-08-21 | — | — | EP | claimed |
| EP-4302747-A1 | SYSTEM FOR DISPENSING A COSMETIC PRODUCT | L'OREAL (FR) | 2024-01-10 | — | — | EP | claimed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| WO-2023062342-A1 | FRAGRANCE AND DISPENSER | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2023-04-20 | — | — | WO | claimed |
| EP-1170343-A1 | INFRARED SENSITIVE COATING LIQUID | Asahi Kasei Kabushiki Kaisha (JP) | 2002-01-09 | — | — | EP | claimed |
| WO-2001027699-A1 | METHOD FOR AUTHENTICATION OF AN ITEM | MERIDIAN CHEMICAL TECHNOLOGIES, INC. (US) | 2001-04-19 | — | — | WO | claimed |
| EP-0433374-B1 | PROCESS FOR THE PRODUCTION OF FLEXOGRAPHIC PRINTING RELIEFS | DU PONT (US) | 1996-04-10 | — | — | EP | claimed |
| US-5354645-A | Exposing crosslinkable elastomers to actinic radiation, removing noncrosslinked areas with developer solvent, such as diethylene glycol dialkyl ethers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-10-11 | — | — | US | claimed |
| WO-1993021295-A1 | LIQUID OR GEL BLEACHING COMPOSITION CONTAINING AMIDOPEROXYACID BLEACH AND PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| EP-0433374-A4 | PROCESS FOR THE PRODUCTION OF FLEXOGRAPHIC PRINTING RELIEFS | — | 1991-08-21 | — | — | EP | claimed |
| EP-0433374-A1 | PROCESS FOR THE PRODUCTION OF FLEXOGRAPHIC PRINTING RELIEFS. | DU PONT (US) | 1991-06-26 | — | — | EP | claimed |
| WO-1990002359-A1 | PROCESS FOR THE PRODUCTION OF FLEXOGRAPHIC PRINTING RELIEFS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-08 | — | — | WO | claimed |
| EP-0355789-A2 | Process for the production of flexographic printing reliefs | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-02-28 | — | — | EP | claimed |
| US-4582635-A | SUSTAINED RELEASE | TAKASAGO PERFUMERY CO., LTD. (JP) | 1986-04-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12239209-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | ALOX15 1971/4885EGFR 4273/4885ALDH1A1 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.